(Q45767689)

English

Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation

scientific article published on 19 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22903385

Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation (English)

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22903385

0 references

electroporation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22903385

10

object named as

Harry Dolstra

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22903385

Nicolaas Schaap

object named as

Nicolaas Schaap

8

0 references

author name string

Tatiana I Novobrantseva

2

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22903385

Hanny Fredrix

3

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22903385

Jamie Wong

4

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22903385

Stuart Milstein

5

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22903385

Hila Epstein-Barash

6

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22903385

Ju Liu

7

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22903385

Robbert van der Voort

9

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22903385

publication date

19 August 2012

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22903385

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22903385

62

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22903385

2

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22903385

285-297

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22903385

https://scigraph.springernature.com/pub.10.1007/s00262-012-1334-1

0 references

Taming cancer by inducing immunity via dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Dendritic cell-based therapeutic cancer vaccines: what we have and what we need

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

The use of dendritic cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Dendritic cells as therapeutic vaccines against cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen-specific CD8+ T cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Immunotherapy of cancer through targeting of minor histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Efficient activation of LRH-1-specific CD8+ T-cell responses from transplanted leukemia patients by stimulation with P2X5 mRNA-electroporated dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Rational design of cationic lipids for siRNA delivery

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Lipid-like materials for low-dose, in vivo gene silencing

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Therapeutic siRNA silencing in inflammatory monocytes in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

HIV controllers: a multifactorial phenotype of spontaneous viral suppression

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Dendritic cell-activated CD44hiCD8+ T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activity.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Dendritic cell immunotherapy: mapping the way.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

mRNA as gene therapeutic: how to control protein expression.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Restoring function in exhausted CD8 T cells during chronic viral infection

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

A novel mechanism is involved in cationic lipid-mediated functional siRNA delivery

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8(+) T cells from HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1334-1

21 January 2018

Identifiers

10.1007/S00262-012-1334-1

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22903385

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22903385

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45767689&oldid=2082024700"